BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29336537)

  • 21. Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology.
    Movsesyan N; Davtyan H; Mkrtichyan M; Petrushina I; Tiraturyan T; Ross T; Agadjanyan MG; Ghochikyan A; Cribbs DH
    Hum Gene Ther; 2010 Nov; 21(11):1569-76. PubMed ID: 20528468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.
    Fu L; Li Y; Hu Y; Zheng Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
    Sci Rep; 2017 Jan; 7():41041. PubMed ID: 28106117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Aβ3-10-KLH vaccine reduced Alzheimer's disease-like pathology and had a sustained effect in Tg-APPswe/PSEN1dE9 mice.
    Meng Y; Ding L; Zhang HY; Yin WC; Yan Y; Cao YP
    Brain Res; 2017 Oct; 1673():72-77. PubMed ID: 28779977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
    Arendash GW; Gordon MN; Diamond DM; Austin LA; Hatcher JM; Jantzen P; DiCarlo G; Wilcock D; Morgan D
    DNA Cell Biol; 2001 Nov; 20(11):737-44. PubMed ID: 11788052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques.
    Hoogerhout P; Kamphuis W; Brugghe HF; Sluijs JA; Timmermans HA; Westdijk J; Zomer G; Boog CJ; Hol EM; van den Dobbelsteen GP
    PLoS One; 2011 Apr; 6(4):e19110. PubMed ID: 21526148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-like peptide vaccines against Abeta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant.
    Li QY; Gordon MN; Chackerian B; Alamed J; Ugen KE; Morgan D
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):133-42. PubMed ID: 20066498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease.
    Olkhanud PB; Mughal M; Ayukawa K; Malchinkhuu E; Bodogai M; Feldman N; Rothman S; Lee JH; Chigurupati S; Okun E; Nagashima K; Mattson MP; Biragyn A
    Vaccine; 2012 Feb; 30(9):1650-8. PubMed ID: 22248819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model.
    Nojima J; Maeda A; Aoki S; Suo S; Yanagihara D; Watanabe Y; Yoshida T; Ishiura S
    Vaccine; 2011 Aug; 29(37):6252-8. PubMed ID: 21726591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.
    Levites Y; Jansen K; Smithson LA; Dakin R; Holloway VM; Das P; Golde TE
    J Neurosci; 2006 Nov; 26(46):11923-8. PubMed ID: 17108166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease.
    Rosset MB; Lui G; Dansokho C; Chaigneau T; Dorothée G
    J Neuroinflammation; 2015 May; 12():95. PubMed ID: 25982697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
    Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
    Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42.
    Town T; Tan J; Sansone N; Obregon D; Klein T; Mullan M
    Neurosci Lett; 2001 Jul; 307(2):101-4. PubMed ID: 11427310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
    Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
    Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.
    Lambert MP; Viola KL; Chromy BA; Chang L; Morgan TE; Yu J; Venton DL; Krafft GA; Finch CE; Klein WL
    J Neurochem; 2001 Nov; 79(3):595-605. PubMed ID: 11701763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Peptide Vaccine Combined with Prior Immunization of a Conventional Diphtheria-Tetanus Toxoid Vaccine Induced Amyloid β Binding Antibodies on Cynomolgus Monkeys and Guinea Pigs.
    Yano A; Ito K; Miwa Y; Kanazawa Y; Chiba A; Iigo Y; Kashimoto Y; Kanda A; Murata S; Makino M
    J Immunol Res; 2015; 2015():786501. PubMed ID: 26539559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.